Essen, Germany
Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-orientated innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik's corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world with more than 35,000 employees. In fiscal 2016, the enterprise generated sales of around €12.7 billion and an operating profit (adjusted EBITDA) of about €2.165 billion. Company information:
21
Total Investments
13
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Finance, Financial Services
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Evonik VC
Recent Investments (21)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Venture Round | •••••• | Jun 2024 | |
| Series B | •••••• | Sep 2023 | |
| Series A | •••••• | Sep 2023 | |
| Venture Round | •••••• | Feb 2023 | |
| Venture Round | •••••• | Dec 2022 | |
•••• ••••
|
Series C | •••••• | Dec 2022 |
|
•••• ••••
|
Series D | •••••• | May 2022 |
|
•••• ••••
|
Series B | •••••• | Mar 2022 |
|
•••• ••••
|
Series D | •••••• | Dec 2021 |
|
•••• ••••
|
Series D | •••••• | Dec 2021 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
